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Abstract Primary chronic headaches cause more dis-
ability and necessitate high utilisation of health care. Our
knowledge is based on selected populations, while
information from the general population is largely lack-
ing. An age and gender-stratiﬁed cross-sectional epide-
miological survey included 30,000 persons aged
30–44 years. Respondents with self-reported chronic
headache were interviewed by physicians. The Interna-
tional Classiﬁcation of Headache Disorders was used. Of
all primary chronic headache sufferers, 80% had con-
sulted their general practitioner (GP), of these 19% had
also consulted a neurologist and 4% had been hospita-
lised. Co-occurrence of migraine increased the probabil-
ity of contact with a physician. A high Severity of
Dependence Scale score increased the probability for
contact with a physician. Complementary and alternative
medicine (CAM) was used by 62%, most often physio-
therapy, acupuncture and chiropractic. Contact with a
physician increased the probability of use of CAM.
Acute headache medications were taken by 87%, while
only 3% used prophylactic medication. GPs manage the
majority of those with primary chronic headache, 1/5
never consults a physician for their headache, while
approximately 1/5 is referred to a neurologist or hospi-
talised. Acute headache medication was frequently
overused, while prophylactic medication was rarely used.
Thus, avoidance of acute headache medication overuse
and increased use of prophylactic medication may
improve the management of primary chronic headaches
in the future.
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Introduction
Headache is a common complaint in the general popula-
tion. The personal burden, social impact and economic cost
for both the sufferer and society are signiﬁcant [1]. The
International Classiﬁcation of Headache Disorders (ICHD-
II) divides headaches into primary and secondary forms
[2]. The most common primary headaches are migraine and
tension-type headaches, while other primary headaches are
rare [3]. The primary headaches are usually paroxysmal,
but 3% of the general population has primary chronic
headache, i.e. more than 15 headache days per months [4].
Headache accounts for 4% of the general practitioners
(GPs) consultations, and 2–4% of these are referred to
specialists or hospitals [5, 6]. Headache is probably the
most common reason for referral to neurologists [5–7].
Approximately 20–30% of all new referrals to out-patients
neurological departments are due to headache [5, 6, 8, 9].
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DOI 10.1007/s10194-011-0391-8Our aim was to investigate primary chronic headache in
the general population in order to evaluate utility of health
services and medication use, since this knowledge is gen-
erally lacking.
Methods
General design
This is a cross-sectional epidemiological survey. A short
postal questionnaire screened for chronic headache
(C15 days/last month and/or C180 days/last year). Parti-
cipants with self-reported chronic headache were invited to
a clinical interview, a physical and neurological examina-
tion conducted by neurological residents. The response rate
of the screening questionnaire was 71% and the parti-
cipation rate of the interview was 74%. Figure 1 shows a
ﬂow chart of the study. The method has been described in
more detail elsewhere [4].
Setting
The study was conducted in 2005 at Akershus University
Hospital, Oslo, Norway. Provision of health care in Nor-
way is based on a decentralized model. The state is
responsible for policy design, overall capacity and quality
of health care and hospital services. Almost all general
practices are private enterprises and their services are
contract based. The GPs are reimbursed through a ﬁxed
annual fee, and fees for the speciﬁc services from the
National Health Insurance and the patients. Each Norwe-
gian citizen has through legislation the right to be on a GPs
list, and it is possible to change GP twice a year. The GP is
the gate keeper for referral to specialists and hospitals
except in emergencies.
Participants
A random sample of 30,000 persons aged 30–44 years and
stratiﬁed for age and gender was drawn from the general
population of eastern Akershus County, Norway. The area
includes rural and urban municipalities in close proximity
to Oslo.
Headache classiﬁcation
The headaches were classiﬁed according to explicit diag-
nostic criteria of the ICHD-II and its relevant revisions, i.e.
the latest update was used in relation to chronic migraine
and medication overuse headache [2, 10–12]. Primary
chronic headache was deﬁned as headache at least 15 days
per months for at least 3 months, not secondary to a head
trauma, brain tumour, etc. Those with medication overuse
as deﬁned by ICHD-II were included as primary chronic
headache [2].
Physician consultation
We deﬁned four levels of contact due to headache, i.e. none
(no physician contact), primary (GP), secondary (neurolo-
gist) and tertiary (hospitalisation). A GP referral is a pre-
requisite for access to neurologists, while both GP and
neurologist can refer to the hospital.
Complementary and alternative contacts
The complementary and alternative medicine (CAM)
forms queried were acupuncture, chiropractic, homeopa-
thy, naprapath, physiotherapy, psychologist and psycho-
motor physiotherapy.
Medication use and dependency
We asked about current medication use, and excluded
medication used for other pain conditions. To assess
dependency like behaviour, we used the The Severity of
Dependence Scale (SDS), which includes ﬁve questions
designed to measure psychological dependence (Table 1)
[13]. The questions apply to the headache medication taken
within the last month. Each item is scored on a 4-point
scale (0–3), and the total maximum score is 15. The
method has been described in detail elsewhere [14]. Fig. 1 Flow chart of the participation
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Data from the interviews were directly entered using SPSS
Data Entry 4.0 (SPSS Inc., Chicago, IL, USA) and statis-
tical analyses were performed using SPSS 15.00 for Win-
dows. For descriptive data, proportions, means and
conﬁdence intervals (CI) are given. Pearson v
2 test was
used for testing signiﬁcance of group differences for cat-
egorical data, Fisher’s exact test was used when appropri-
ate. Student’s t test was used for numerical data.
Signiﬁcance levels were set at p\0.05 and 95% CI were
calculated. CI and probabilities are not given when n\5.
Ethical issues
The Regional Committee for Medical Research Ethics and
the Norwegian Social Science Data Services approved the
study. All participants gave informed consent.
Results
Participants and headache diagnoses
A total of 405 participants (22% men and 78% women) had
primary chronic headaches. Ninety-ﬁve percent (n = 384)
had chronic tension-type headache (CTTH), 4% (n = 15)
had chronic migraine (CM), and 2% had other primary
chronic headache, i.e. new daily persistent headache
(n = 4) and chronic cluster headache (n = 1). Forty-nine
percent (n = 199) had co-occurrence of migraine and 46%
(n = 185) had medication overuse. The diagnoses are not
mutually exclusive.
Physician consultation pattern
Table 2 shows the physician and CAM contact pattern.
Twenty percent (79/405) had never consulted their GP
because of headache, while 80% (326/405) had consulted
their GP. The GP referred 1/4 with primary chronic head-
ache to neurologist and 4% had been hospitalised.
Signiﬁcantly more women than men had had contact with
their GP (83 vs. 73%, p = 0.044), while referral was not
inﬂuenced by gender.
Complementary and alternative medicine
CAM was used by 62% (253/405) (Table 2). Physiother-
apy, acupuncture and chiropractic were most frequently
used. The use of CAM was signiﬁcantly higher among
those who had consulted a physician compared to those
who had not such contact (p\0.001). Of those who did
not consult a physician 30% had used CAM to treat their
headache. Signiﬁcantly more women than men had used
CAM (67 vs. 48%, p = 0.002), physiotherapy being the
only subgroup with a signiﬁcant difference (57% women
vs. men 36%, p = 0.001).
Co-occurrence of migraine
Table 3 shows that co-occurrence of migraine as compared
to no co-occurrence of migraine signiﬁcantly increased the
physician contact (p\0.001), while referral to hospital
was not signiﬁcantly different in the two groups.
The overall use of CAM was not inﬂuenced by
migraine, but signiﬁcantly more with than without co-
occurrence of migraine had acupuncture and physiotherapy
(p\0.05).
Co-occurrence of medication overuse
Medication overuse neither inﬂuenced the consultation
pattern nor CAM. However, signiﬁcantly more with than
without medication overuse had co-occurrence of migraine
(p = 0.001).
Use of medication
Acute medication was used by 87, and 9% used it on a
daily basis. A higher proportion of participants with than
without co-occurrence of migraine used acute medication
(93 vs. 81%, p\0.001). More women than men used acute
Table 1 The ﬁve questions of the Severity Dependence Scale (SDS) adapted for headache medication
1 Do you think your use of headache medication was out of control? (never/almost never = 0, sometimes = 1, often = 2, always/nearly
always = 3)
2 Did the prospect of missing a dose make you anxious or worried? (scoring as for question 1)
3 Did you worry about your use of your headache medication? (scoring as for question 1)
4 Did you wish you could stop? (scoring as for question 1)
5 How difﬁcult would you ﬁnd it to stop or go without your headache medication? (not difﬁcult = 0, quite difﬁcult = 1, very difﬁcult = 2,
impossible = 3)
‘‘Your headache medication’’ was in the interview replaced with the name of the individually relevant headache medication. Each item is scored
on a 4-point scale (0–3), and the total maximum score is 15
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123medication (89 vs. 79%, p = 0.009). Participants using
acute medication had signiﬁcantly more physician contact
than participants not using acute medication (82 vs. 18%,
p = 0.035).
Simple analgesic such as paracetamol (acetaminophen)
andibuprofenweremostfrequentlyoverused62%(n = 115),
followed by combination analgesics 28% (n = 51). Triptans,
ergotamines, opioids and combination of acute medications
were overused by 10% (n = 10). Co-occurrence of migraine
did not inﬂuence which drugs that were overused except that
triptans were only overused by those with co-occurrence of
migraine. Only 4% used prophylactic treatment, with signif-
icantly more use in participants with than without co-occur-
rence of migraine (6 vs. 2%, p = 0.03).
The SDS score was signiﬁcantly higher in those with
than without physician contact [4.3 (95% CI 4.0–4.6) vs.
3.2 (95% CI 2.6–3.8)], as well as in those with than without
medication overuse for all levels of physician contact
(Fig. 2).
Discussion
Presentation of main ﬁndings
Our main ﬁnding is that the majority of primary chronic
headache sufferers (80%) consulted their GP due to their
headache, while only 20% consulted a neurologist. Co-
occurrence of migraine and a high SDS score increased the
physician consulting rate. The use of CAM was high (62%)
and higher if a physician had been consulted than not.
Prophylactic headache medication was rarely used.
Methodological considerations
The sample size was chosen to ensure adequate numbers of
participants with chronic headache for the accurate
descriptive statistics. The large sample and high response
rates should ensure representative data from the general
population.
Table 2 Contact and treatment pattern in relation to different primary chronic headache diagnoses
CTTH
without
medication
overuse
(N = 216)
%( n)
CTTH with
medication
overuse
(N = 169)
%( n)
Chronic migraine
without
medication
overuse (N = 3)
%( n)
Chronic
migraine with
medication
overuse
(N = 14)
%( n)
Other primary
chronic headache
without medication
overuse (N = 3)
%( n)
Other primary
chronic headache
with medication
overuse (N = 7)
%( n)
All primary
headaches
(N = 405)
%( n)
Contact level
None 22 (47) 17 (28) 0 (0) 14 (2) 33 (1) 14 (1) 20 (79)
Primary 78 (169) 83 (141) 100 (3) 86 (12) 67 (2) 86 (6) 80 (326)
Secondary 16 (34) 20 (33) 33 (1) 36 (5) 67 (2) 71 (5) 19 (76)
Tertiary 4 (9) 4 (7) 0 (0) 0 (0) 33 (1) 0 (0) 4 (17)
Complementary and alternative medicine
Acupuncture 30 (65) 34 (58) 0 (0) 57 (8)
d 67 (2) 43 (3) 33 (133)
Chiropractic 29 (62) 28 (47) 0 (0) 29 (4) 33 (1) 14 (1) 28 (113)
Homeopathy 11 (23) 10 (17) 0 (0) 14 (2) 33 (1) 29 (2) 11 (44)
Naprapath 6 (13) 4 (6) 0 (0) 0 (0) 33 (1) 0 (0) 5 (20)
Physiotherapy 50 (109) 56 (94) 0 (0) 57 (8) 33 (1) 43 (3) 52 (211)
Psychologist 2 (4) 2 (3) 0 (0) 0 (0) 33 (1) 0 (0) 2 (8)
Psychomotor
physiotherapy
6 (14) 10 (17) 0 (0) 0 (0) 0 (0) 0 (0) 8 (31)
Any CAM 61 (132) 65 (110) 0 (0) 64 (9) 67 (2) 57 (4) 62 (253)
Medication use
Acute
medication
75 (163)
b 100 (169)
a,c 100 (3) 100 (14) 100 (3) 100 (7) 87 (352)
Prophylactic
medication
3 (7) 3 (5) 0 (0) 7 (1) 0 (0) 14 (1) 3 (14)
Individual diagnoses are not mutually exclusive
a p\0.001 for CTTH with medication overuse versus CTTH without medication overuse
b p\0.001 for CTTH without medication overuse versus all other primary headaches
c p\0.001 for CTTH with medication overuse versus all other primary headaches
d p\0.05 for chronic migraine with medication overuse versus all other primary headache
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order to target the highest number of participants with
‘‘pure’’ primary chronic headache, as the prevalence is
lower in younger people, and older people have a higher
risk of co-morbidity with other disorders. Furthermore,
data from the Norwegian prescription registry indicate that
the drug prescription pattern is different in people below
and above 50 years of age [15].
Two neurological residents with experience in headache
diagnosticsconductedallinterviews.Thedifferentheadache
diagnoses were equally frequently set by both physicians,
suggesting that inter-observer variation was low. The head-
ache diagnoses were equally frequent in participants inter-
viewed at the clinic and in those interviewed by telephone.
Our data on medication use and health care utilisation
are based on self-reports and therefore open to recall bias,
although there is no reason to suspect systematic bias.
Health registry data are, however, often incomplete and not
necessarily more precise. In addition, registry data do not
exist for a majority of treatment contacts outside traditional
conventional medicine.
Physician contact
Twenty percent of the subjects with primary chronic
headache had never consulted a physician due to headache.
Table 3 Contact and treatment pattern for participants with primary chronic headaches
All primary headaches without
co-occurrence of migraine
(N = 206) % (n)
All primary headaches with
co-occurrence of migraine
(N = 199) % (n)
All primary headaches
without medication overuse
(N = 220) % (n)
All primary headaches
with medication overuse
(N = 185) % (n)
Contact level
None 28 (57) 11 (22)
a 22 (48) 17 (31)
Primary 72 (149) 89 (177)
a 78 (172) 83 (154)
Secondary 15 (31) 23 (45)
a 16 (36) 22 (40)
Tertiary 5 (10) 4 (7) 5 (10) 4 (7)
Complementary and alternative medicine
Acupuncture 28 (57) 38 (76)
b 30 (67) 36 (66)
Chiropractic 26 (54) 30 (59) 29 (63) 27 (50)
Homeopathy 10 (20) 12 (24) 11 (24) 11 (20)
Naprapath 5 (10) 5 (10) 6 (14) 3 (86)
Physiotherapy 47 (97) 57 (114)
b 50 (110) 55 (101)
Psychologist 2 (4) 2 (4) 2 (5) 2 (3)
Psychomotor
physiotherapy
7 (14) 9 (17) 6 (14) 9 (17)
Any CAM 58 (120) 67 (133) 61 (134) 64 (119)
Medication use
Acute
medication
81 (167) 93 (185)
a 76 (167) 100 (185)
c
Prophylactic
medication
1 (3) 6 (11)
b 3 (7) 4 (7)
Co-occurrence of
migraine
0 (0) 100 (199) 42 (92) 58 (107)
c
Individual contacts and treatments are not mutually exclusive
a,b p\0.001 and p\0.05, respectively, for all primary chronic headaches with versus without migraine
c p\0.01 for all primary chronic headaches with versus without medication overuse
Fig. 2 Severity Dependence Scale (SDS) scores in participants with
primary chronic headache with (black) or without (dashed) medica-
tion overuse versus contact level
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123The reason for this is unknown, but a possible reason may
be due to the low status of headache. For some people, the
chronic headache may represent just a minor problem in a
co-morbidity of other pain condition [5, 16]. It may also be
that some of those not consulting a physician prefer CAM
as a treatment option or they might manage their headache
adequately by themselves and do not feel a need for further
help. In a study conducted in a primary care population,
28% of those with chronic headache reported that they did
not need a consultation for their headache [17]. Thus, this
ﬁgure corresponds well with our ﬁgure. Eighty percent
consulted their GP for their primary chronic headache, and
1/4 was referred to a neurologist. The referral rate to
neurologists is quite low considering that the management
of chronic headaches is a real challenge that is often not
successful in primary care. Other population-based studies
on chronic headache found that 40–60% consulted their GP
and 13–28% was referred to a neurologist during the pre-
vious 6–12 months [18–20].
In our study, 4% had been admitted to hospital in-patient
treatment due to their headache. This is similar to a
European general population study [18], but low compared
to a US study [20]. The latter might be accounted for by
medication overuse headache primarily being caused by
analgesics and triptans in Europe, while barbiturates and
opioids are major challenges which often require hospi-
talisation in medication overuse headache in USA.
Co-occurrence of migraine increased the consultation
rate. Similarly, migraine caused a higher consultation rate
than tension-type headache in the general Danish popula-
tion [21, 22]. However, a French and an American study
found the consultation rate was not inﬂuenced by co-
occurrence of migraine among those who had chronic
headache [18, 20].
Use of complementary and alternative medicine
Over 60% of those with primary chronic headache had, at
some point, used CAM because of their headache. Other
studies have found that 40–90% of chronic headache suf-
ferers from different clinical settings use CAM for their
headache [23–25]. This indicates that chronic headache
sufferers like other chronic pain sufferers are likely to use
CAM as treatment [26, 27].
One reason for the high use of CAM despite the wide
range of traditional medical treatments for headache, may
be failure to achieve optimal control with medication.The
use of CAM is high and increasing in Norway and
worldwide [28, 29] and approximately 1/3 person in the
Norwegian general population who use CAM use it
because of headache [30]. A survey conducted in the UK
among CAM providers conﬁrmed that headache is one of
the conditions believed to beneﬁt mostly from different
CAM subtypes [31].
Use of medication
Eighty-seven percent used any acute medication for their
primary chronic headache, which is similar to the 84%
found in France [18]. Forty-six percent of those with pri-
mary chronic headache overused medication, which is a
high proportion compared to the 25–35% found in three
other population studies [19, 32, 33]. Part of this might be
explained by the use of different diagnostic criteria, i.e.
ICHD II versus criteria suggested by Silberstein [34, 35].
The distribution of type of overused medication is com-
parable to other population-based studies where simple
analgesics are most frequently overused and paracetamol
the main overused drug [18, 20, 33]. Paracetamol (acet-
aminophen) and ibuprofen are available as over-the-coun-
ter (OTC) drugs and are the most commonly used simple
analgesics in Norway.
The prevalence of medication overuse may also be
difﬁcult to compare across studies using different data
collection methods. The condition may, in some settings,
be underreported.
The proportion of medication overuses among chronic
headache sufferers in the general population are lower than
that seen in headache clinics, and the spectrum of overused
medication differs slightly [18, 32, 33, 36–38].
In US it has been found that 23% of chronic headache
used acute medication on a daily basis [20] in contrast to
only 9% in the Norwegian general population. Norwegian
results comparable to those from the US are only found in
neurology out-patient settings [39].
The rare use of prophylactic treatment is surprising
considering the diagnosis of primary chronic headache and
the frequent use of acute headache medication.
The SDS was signiﬁcantly higher in those with than
without medication overuse for all levels of physician
contact (Fig. 2). Primary chronic headache participants in
contact with physicians had signiﬁcantly higher SDS than
those without such contact. Thus, our results support the
hypothesis that persons with physician contact differ from
those without such contact, and that people with physician
contact are likely to be more severe headache sufferers
with more disability, dependency-like characteristics and
other headache-related problems.
To alleviate the world wide problem of medication
overuse headache, it is important to educate those with
medication overuse headache to reduce their medication
consumption. We have previously described that a short
advice can reduce the medication use considerable and this
also leads to the reduction of the headache frequency [40].
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Primary chronic headache is most often treated by health
professionals, though 1/5 never consulted a physician. Co-
occurrence ofmigraine increases physician consultations and
affects treatment level within the health care system. CAM is
alsoafrequentlyusedtreatmentoption.Thechronicheadache
spectrum seen by GPs and neurologists differs. The high
degreeofself-management,thehighproportionofmedication
overuse and the frequent use of less well-documented treat-
ment forms is a major concern. Improved management by
healthprofessionals,notleastGPs,aswellasincreaseduseof
prophylactic treatment and detoxiﬁcation of medication
overuseislikelytoalleviatetheburdenforthosewithprimary
chronic headache. However, those patients who do not seek
medical contact also deserve attention.
Acknowledgments Akershus University Hospital kindly provided
research facilities. This study was supported by Grants from the East
Norway and South East Norway. Regional Health Authority and
Faculty Division Akershus University Hospital. ESK was supported
by the University of Oslo.
Conﬂict of interest None.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution and reproduction in any medium, provided the original
author(s) and source are credited.
References
1. Jensen R, Stovner LJ (2008) Epidemiology and comorbidity of
headache. Lancet Neurol 7:354–361
2. Headache Classiﬁcation Subcommittee of the International
Headache Society (2004) The international classiﬁcation of
headache disorders, 2nd edn. Cephalalgia 24(Suppl 1):9–160
3. Rasmussen BK, Jensen R, Schroll M, Olesen J (1991) Epidemi-
ology of headache in a general population—a prevalence study.
J Clin Epidemiol 44:1147–1157
4. Grande RB, Aaseth K, Gulbrandsen P, Lundqvist C, Russell MB
(2008) Prevalence of primary chronic headache in a population-
based sample of 30- to 44 year-old persons. The Akershus study
of chronic headache. Neuroepidemiology 30:76–83
5. Ridsdale L, Clark LV, Dowson AJ, Goldstein LH, Jenkins L,
McCrone P, Morgan M, Seed PT (2007) How do patients referred
to neurologists for headache differ from those managed in pri-
mary care? Br J Gen Pract 57:388–395
6. Latinovic R, Gulliford M, Ridsdale L (2006) Headache and
migraine in primary care: consultation, prescription, and referral
rates in a large population. J Neurol Neurosurg Psychiatry
77:385–387
7. Cockerell OC, Goodridge DM, Brodie D, Sander JW, Shorvon
SD (1996) Neurological disease in a deﬁned population: the
results of a pilot study in two general practices. Neuroepidemi-
ology 15:73–82
8. Wiles CM, Lindsay M (1996) General practice referrals to a
department of neurology. J R Coll Physicians Lond 30:426–431
9. Bekkelund SI, Albretsen C (2002) Evaluation of referrals from
general practice to a neurological department. Fam Pract
19:297–299
10. Silberstein SD, Olesen J, Bousser MG, Diener HC, Dodick D,
First M, Goadsby PJ, Go ¨bel H, Lainez MJ, Lance JW, Lipton RB,
Nappi G, Sakai F, Schoenen J, Steiner TJ, International Headache
Society (2005) The International Classiﬁcation of Headache
Disorders, 2nd Edition (ICHD-II)–revision of criteria for 8.2
Medication-overuse headache. Cephalalgia 25:460–465
11. Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby
PJ, Go ¨bel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai
F, Schoenen J, Silberstein SD, Steiner TJ, International Headache
Society (2006) New appendix criteria open for a broader concept
of chronic migraine. Cephalalgia 26:742–746
12. Cephalalgia (2006) ERRATUM. Cephalalgia 26:360
13. Gossop M, Darke S, Grifﬁths P, Hando J, Powis B, Hall W,
Strang J (1995) The Severity of Dependence Scale (SDS): psy-
chometric properties of the SDS in English and Australian sam-
ples of heroin, cocaine and amphetamine users. Addiction
90:607–614
14. Grande RB, Aaseth K, Saltyte BJ, Gulbrandsen P, Russell MB,
Lundqvist C (2009) The Severity of Dependence Scale detects
people with medication overuse: the Akershus study of chronic
headache. J Neurol Neurosurg Psychiatry 80:784–789
15. Norwegian Prescription Database (NorPD) (2011) http://www.
reseptregisteret.no/.Accessed 18-02-2011
16. Scher AI, Stewart WF, Lipton RB (2006) The comorbidity of
headache with other pain syndromes. Headache 46:1416–1423
17. Coeytaux RR, Linville JC (2007) Chronic daily headache in a
primary care population: prevalence and headache impact test
scores. Headache 47:7–12
18. Lanteri-Minet M, Auray JP, El Hasnaoui A, Dartigues JF, Duru
G, Henry P, Lucas C, Pradalier A, Chazot G, Gaudin AF (2003)
Prevalence and description of chronic daily headache in the
general population in France. Pain 102:143–149
19. Lu SR, Fuh JL, Chen WT, Juang KD, Wang SJ (2001) Chronic
daily headache in Taipei, Taiwan: prevalence, follow-up and
outcome predictors. Cephalalgia 21:980–986
20. Scher AI, Lipton RB, Stewart WF, Bigal ME (2010) Patterns of
medication use by chronic and episodic headache sufferers in the
general population: results from the frequent headache epidemi-
ology study. Cephalalgia 30:321–328
21. Rasmussen BK, Jensen R, Olesen J (1992) Impact of headache on
sickness absence and utilisation of medical services: a Danish
population study. J Epidemiol Community Health 46:443–446
22. Lyngberg AC, Rasmussen BK, Jorgensen T, Jensen R (2005)
Secular changes in health care utilization and work absence for
migraine and tension-type headache: a population based study.
Eur J Epidemiol 20:1007–1014
23. Rossi P, Di LG, Malpezzi MG, Faroni J, Cesarino F, Di Lorenzo
G, Nappi G (2005) Prevalence, pattern and predictors of use of
complementary and alternative medicine (CAM) in migraine
patients attending a headache clinic in Italy. Cephalalgia
25:493–506
24. Rossi P, Di Lorenzo G, Faroni J, Malpezzi MG, Cesarino F,
Nappi G (2006) Use of complementary and alternative medicine
by patients with chronic tension-type headache: results of a
headache clinic survey. Headache 46:622–631
25. Gaul C, Eismann R, Schmidt T, May A, Leinisch E, Wieser T,
Evers S, Henkel K, Franz G, Zierz S (2009) Use of comple-
mentary and alternative medicine in patients suffering from pri-
mary headache disorders. Cephalalgia 29:1069–1078
26. Artus M, Croft P, Lewis M (2007) The use of CAM and con-
ventional treatments among primary care consulters with chronic
musculoskeletal pain. BMC Fam Pract 8:26
J Headache Pain (2012) 13:113–120 119
12327. Rosenberg EI, Genao I, Chen I, Mechaber AJ, Wood JA, Faselis
CJ, Kurz J, Menon M, O’Rorke J, Panda M, Pasanen M, Staton L,
Calleson D, Cykert S (2008) Complementary and alternative
medicine use by primary care patients with chronic pain. Pain
Med 9:1065–1072
28. Fonnebo V, Launso L (2009) High use of complementary and
alternative medicine inside and outside of the government-funded
health care system in Norway. J Altern Complement Med
15:1061–1066
29. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van
Rompay M, Kessler RC (1998) Trends in alternative medicine
use in the United States, 1990–1997: results of a follow-up
national survey. JAMA 280:1569–1575
30. StatisticsNorway(2011)TheNorwegianHealthInterviewSurvey.
http://www.ssb.no/ssp/utg/201002/05/tab-2010-05-03-03.html/.
Accessed 10-03-2011
31. Long L, Huntley A, Ernst E (2001) Which complementary and
alternative therapies beneﬁt which conditions? A survey of the
opinions of 223 professional organizations. Complement Ther
Med 9:178–185
32. Castillo J, Munoz P, Guitera V, Pascual J (1999) Kaplan Award
1998. Epidemiology of chronic daily headache in the general
population. Headache 39:190–196
33. Colas R, Munoz P, Temprano R, Gomez C, Pascual J (2004)
Chronic daily headache with analgesic overuse: epidemiology
and impact on quality of life. Neurology 62:1338–1342
34. Siberstein SD, Lipton RB, Solomon S, Mathew NT (1994)
Classiﬁcation of daily and near-daily headaches: proposed revi-
sions to the IHS criteria. Headache 34:1–7
35. Silberstein SD, Lipton RB, Sliwinski M (1996) Classiﬁcation of
daily and near-daily headaches: ﬁeld trial of revised IHS criteria.
Neurology 47:871–875
36. Dowson AJ (2003) Analysis of the patients attending a specialist
UK headache clinic over a 3 year period. Headache 43:14–18
37. Zeeberg P, Olesen J, Jensen R (2006) Probable medication-
overuse headache: the effect of a 2 month drug-free period.
Neurology 66:1894–1898
38. Meskunas CA, Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME
(2006) Medications associated with probable medication overuse
headache reported in a tertiary care headache center over a
15 year period. Headache 46:766–772
39. Bekkelund SI, Salvesen R (2002) Drug-associated headache is
unrecognized in patients treated at a neurological centre. Acta
Neurol Scand 105:120–123
40. Grande RB, Aaseth K, S ˇaltyt_ e Bent J, Lundqvist C, Russell MB
(2011) Reduction of medication-overuse headache after modiﬁed
brief intervention. The Akershus study on chronic headache. Eur
J Neurol 18:129–137
120 J Headache Pain (2012) 13:113–120
123